Benchmark Stands Firm on $570 Price Target for Strategy, Projecting 500%+ Upside

Investment firm Benchmark has reaffirmed its bullish stance on Strategy, maintaining both its Buy rating and a $570 price target for the company. The decision comes in response to Strategy's newly introduced active two-way capital management framework, which analysts believe could serve as a powerful catalyst for significant value creation.

According to Benchmark's latest assessment, the upside potential for Strategy exceeds 500% from current trading levels — a bold projection that underscores the firm's confidence in the company's evolving financial strategy. The new capital framework, which operates in both directions, is seen as a more dynamic and flexible approach to managing the company's assets and liabilities.

The two-way capital management model allows Strategy to not only deploy capital into Bitcoin acquisitions but also to actively manage its financial position in response to market conditions. This level of adaptability is what appears to have impressed Benchmark's analysts, who view it as a fundamental shift in how the company approaches long-term value building.

Strategy, formerly known as MicroStrategy, has become one of the most closely watched names in the intersection of corporate finance and cryptocurrency markets. Its aggressive Bitcoin treasury strategy has attracted both widespread praise and scrutiny, making analyst coverage from major investment firms particularly noteworthy.

The reiteration of the $570 price target signals that Benchmark sees no reason to revise its long-term outlook despite market volatility. In fact, the introduction of the new framework seems to have reinforced their conviction rather than introduced doubt.

For investors keeping a close eye on crypto-adjacent equities, Benchmark's unwavering position offers a compelling data point. With more than 500% projected upside still on the table, Strategy remains one of the most aggressively bullish calls in the sector. Whether the market will validate this thesis remains to be seen, but for now, Benchmark is doubling down on its high-conviction view.